Continuum Advisory »

Janux Therapeutics shares owned by Continuum Advisory

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Continuum Advisory from 13F filings

Historical chart of Continuum Advisory investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Continuum Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Continuum Advisory

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.5k 49 51.94

More positions owned by Continuum Advisory

Capital Group Dividend Value Etf Etf (CGDV)
Apple Stock (AAPL)
Jpmorgan Core Plus Bond Etf Jpmorgan Core Plus Bond Fund Etf (JCPB)
Microsoft Corp Stock (MSFT)
Vanguard Extended Market Etf Etf (VXF)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares 20 Year Treasury Bond Etf Etf (TLT)
Invesco Qqq Trust Series I Etf (QQQ)
Amazon Stock (AMZN)
Vanguard Total Bond Market Etf Etf (BND)
Barnes Group Stock (B)
Spdr Msci Usa Strategicfactors Etf Etf (QUS)
Vanguard Large-cap Etf Etf (VV)
Ishares S&p 100 Etf Etf (OEF)
Ishares Core S&p 500 Etf Etf (IVV)

View all positions for Continuum Advisory

Top funds holding Janux Therapeutics

RA Capital Management
FMR
OrbiMed Advisors
BVF
Adage Capital Partners GP
Citadel Advisors
Henderson Group
BlackRock
Vanguard Group
Rtw Investments
Cormorant Asset Management
Lord, Abbett & Co
Geode Capital Management
State Street Corporation
Avidity Partners Management

View all funds holding Janux Therapeutics